Capstone Therapeutics Corp/ US14068E2081 /
| 5/6/2024 4:46:03 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 5.0000USD | - | 300 Turnover: 1,500 |
-Bid Size: - | -Ask Size: - | 5.0000 | 5.0000 |
GlobeNewswire
5/7/2018
LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China
GlobeNewswire
7/17/2017
Capstone Therapeutics Announces Transaction for Sale of Shares of Its Common Stock and Secured Loan
GlobeNewswire
12/19/2016
Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study
